ArticleFrontiers in oncology2024

Predicting grade II-IV bone marrow suppression in patients with cervical cancer based on radiomics and dosiomics.

Yanchun Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.